Analysis of the CCLE dataset revealed that among 33 metastatic melanoma cell lines, 70% exhibited low ALDH2 expression, whereas the remaining 30% showed relatively high expression levels (Figure 2a). This evidence concerns the gene ALDH2 and melanoma.